Gene fusions are strong driver mutations in cancer and can be used as a diagnostic tool to predict different tumour phenotypes and treatments. Several fusion detection algorithms for RNA-Seq data have been developed, but all of them report a consistently high number of false positive events. Therefore, new methods are crucial to accurately identify potential fusions that may be key drivers of oncogenesis. We developed Fusion Validator, a new filtering tool able to discriminate false positive fusion transcripts from real fusions and significantly reduce the number of candidates to assess for experimental validation. Fusion Validator perform a local realignment of reads on each fusion transcript sequence and tries to close the gap aroun...
Malignant melanoma is a very aggressive tumor with a high metastatic potential and persistently incr...
Neuroendocrine tumors (NETs) are rare neoplasias of hormone-producing cells largely emerging from th...
In this PhD thesis, the capability of analytical systems based on high-resolution mass spectrometry ...
Gene fusions are strong driver mutations in cancer and can be used as a diagnostic tool to predict d...
Gene fusions are strong driver mutations in cancer and can be used as a diagnostic tool to predict d...
Hereditary hemolytic anemias (HHAs) embrace a highly heterogeneous group of chronic disorders with a...
CBFA2T3-GLIS2 is a fusion gene identified in 7-8% of pediatric acute myeloid leukemia with poor outc...
A dramatic change in cell phenotype is sometimes seen in an advanced stage of mouse skin carcinogene...
PhDBACKGROUND: Radiation exposure to the abdominal region causes intestinal toxicity and is also cap...
In approximately 70% of newly diagnosed cases, CLL presents at an early clinical stage and is manage...
There is accumulating evidence that the escape from the phenomenon of in vitro senescence, or immort...
Chinese hamster ovary (CHO) cells are the predominant host cell type used in the production of recom...
Mucinous Ovarian Carcinoma (MOC) is a rare histological subtype, comprising 3-4% of all epithelial o...
Specific language impairment (SLI) is a complex neurodevelopmental disorder defined as an unexpected...
Cystic Fibrosis (CF) is an autosomal recessive monogenic disorder caused by mutations in the cystic ...
Malignant melanoma is a very aggressive tumor with a high metastatic potential and persistently incr...
Neuroendocrine tumors (NETs) are rare neoplasias of hormone-producing cells largely emerging from th...
In this PhD thesis, the capability of analytical systems based on high-resolution mass spectrometry ...
Gene fusions are strong driver mutations in cancer and can be used as a diagnostic tool to predict d...
Gene fusions are strong driver mutations in cancer and can be used as a diagnostic tool to predict d...
Hereditary hemolytic anemias (HHAs) embrace a highly heterogeneous group of chronic disorders with a...
CBFA2T3-GLIS2 is a fusion gene identified in 7-8% of pediatric acute myeloid leukemia with poor outc...
A dramatic change in cell phenotype is sometimes seen in an advanced stage of mouse skin carcinogene...
PhDBACKGROUND: Radiation exposure to the abdominal region causes intestinal toxicity and is also cap...
In approximately 70% of newly diagnosed cases, CLL presents at an early clinical stage and is manage...
There is accumulating evidence that the escape from the phenomenon of in vitro senescence, or immort...
Chinese hamster ovary (CHO) cells are the predominant host cell type used in the production of recom...
Mucinous Ovarian Carcinoma (MOC) is a rare histological subtype, comprising 3-4% of all epithelial o...
Specific language impairment (SLI) is a complex neurodevelopmental disorder defined as an unexpected...
Cystic Fibrosis (CF) is an autosomal recessive monogenic disorder caused by mutations in the cystic ...
Malignant melanoma is a very aggressive tumor with a high metastatic potential and persistently incr...
Neuroendocrine tumors (NETs) are rare neoplasias of hormone-producing cells largely emerging from th...
In this PhD thesis, the capability of analytical systems based on high-resolution mass spectrometry ...